Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 122 articles:
HTML format



Single Articles


    June 2022
  1. HUANG YM, Lin PH
    IgG4-Related Ophthalmic Disease.
    N Engl J Med. 2022;386:2315.
    PubMed    


  2. JEBARAJ A, Lin A
    Sclerokeratitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:2221.
    PubMed    


    April 2022
  3. WARE J, Hovorka R
    Closed-Loop Control in Very Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2022;386:1482-1483.
    PubMed    


  4. RING BL
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    PubMed    


  5. MURATA Y, Takita M, Kami M
    Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:1482.
    PubMed    


  6. KUTER DJ, Efraim M, Mayer J, Trneny M, et al
    Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:1421-1431.
    PubMed     Abstract available


    March 2022
  7. SPERLING MA, Laffel LM
    Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
    N Engl J Med. 2022;386:1155-1164.
    PubMed    


  8. COSTENBADER KH
    A New IMiD for Systemic Lupus Erythematosus - Tempering Our Excitement.
    N Engl J Med. 2022;386:1085-1086.
    PubMed    


  9. MERRILL JT, Werth VP, Furie R, van Vollenhoven R, et al
    Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
    N Engl J Med. 2022;386:1034-1045.
    PubMed     Abstract available


    January 2022
  10. YONG GY, Lim AL
    Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2022;386:374.
    PubMed    


  11. WARE J, Allen JM, Boughton CK, Wilinska ME, et al
    Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
    N Engl J Med. 2022;386:209-219.
    PubMed     Abstract available


  12. VIDENOVIC A, Babu S, Zhao B, Reda HM, et al
    Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.
    N Engl J Med. 2022;386:173-180.
    PubMed    


  13. PAVORD S, Lester W, Hunt BJ
    Clinical Features of VITT. Reply.
    N Engl J Med. 2022;386.
    PubMed    


  14. CHITI A
    Clinical Features of VITT.
    N Engl J Med. 2022;386.
    PubMed    


    December 2021
  15. LACY J, Pavord S, Brown KE
    VITT and Second Doses of Covid-19 Vaccine.
    N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
    PubMed    


  16. DILLY B, Bomahou C
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2021;385:2377.
    PubMed    


  17. BRADBURY CA, Hill Q, Greenwood R
    Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
    N Engl J Med. 2021;385:2201-2202.
    PubMed    


  18. VAN DIJK WEM, Schutgens REG
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2201.
    PubMed    


  19. GHANIMA W, Zaja F, Michel M
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200-2201.
    PubMed    


  20. CHEN S, Dong C, Wei JC
    Mycophenolate Mofetil for Immune Thrombocytopenia.
    N Engl J Med. 2021;385:2200.
    PubMed    


    November 2021
  21. O'CONNELL J, Nathan DM, O'Brien T, O'Keeffe DT, et al
    Treatment of Diabetes - To Pump or Not to Pump.
    N Engl J Med. 2021;385:2092-2095.
    PubMed    


  22. MANDL A, Burbelo PD, Di Pasquale G, Tay YS, et al
    Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
    N Engl J Med. 2021;385:1974-1980.
    PubMed     Abstract available


  23. BJORNSTAD P, Drews K, Zeitler PS
    Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
    N Engl J Med. 2021;385:2016.
    PubMed    


  24. NELSON RG, Hanson RL, Knowler WC
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:2015.
    PubMed    


  25. YANG W, Wang C
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:2014-2015.
    PubMed    


  26. MOUGIAKAKOS D, Kronke G, Schett G
    More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2021;385:e67.
    PubMed    


  27. KONIG MF, Paul S
    More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:e67.
    PubMed    


  28. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
    Decline in Pathogenic Antibodies over Time in VITT.
    N Engl J Med. 2021;385:1815-1816.
    PubMed    


    October 2021
  29. BERENTSEN S, Barcellini W
    Autoimmune Hemolytic Anemias.
    N Engl J Med. 2021;385:1407-1419.
    PubMed    


    September 2021
  30. WERTH VP, Joly P, Chen DM
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
    N Engl J Med. 2021;385:1056.
    PubMed    


  31. HOPKINS ZH, Wu BC, Nousari CH
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
    N Engl J Med. 2021;385:1055-1056.
    PubMed    


  32. BOLTON-MAGGS PHB, George JN
    Immune Thrombocytopenia Treatment.
    N Engl J Med. 2021;385:948-950.
    PubMed    


  33. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
    N Engl J Med. 2021;385:885-895.
    PubMed     Abstract available


    August 2021
  34. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    PubMed     Abstract available


  35. GOYAL RK
    Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
    N Engl J Med. 2021;385:576.
    PubMed    


  36. AKTURK HK, Shah VN
    Gastric Emptying Abnormalities in Diabetes Mellitus.
    N Engl J Med. 2021;385:575-576.
    PubMed    


  37. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
    CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:567-569.
    PubMed    


    July 2021
  38. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
    Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
    N Engl J Med. 2021;385:451-460.
    PubMed    


  39. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
    A Periodic Problem.
    N Engl J Med. 2021;385:e17.
    PubMed    


  40. AVELAR RODRIGUEZ D, Orkin J
    An Icteric Tongue.
    N Engl J Med. 2021;385:e16.
    PubMed    


  41. MORAN-THOMAS A
    One Hundred Years of Insulin for Some.
    N Engl J Med. 2021;385:293-295.
    PubMed    


  42. GOGLIN SE, Margaretten ME
    Malar Rash.
    N Engl J Med. 2021;385:164.
    PubMed    


  43. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    PubMed    


    June 2021
  44. O'CONNELL KA, LaChance AH
    Dermatomyositis.
    N Engl J Med. 2021;384:2437.
    PubMed    


  45. SEEKER P, Osswald S
    Tongue Discoloration.
    N Engl J Med. 2021;384:e102.
    PubMed    


  46. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
    Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    N Engl J Med. 2021;384:2295-2305.
    PubMed     Abstract available


    May 2021
  47. JAYNE DRW, Merkel PA, Bekker P
    Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2021;384:e81.
    PubMed    


  48. MATSUO Y, Miyabe Y
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    PubMed    


  49. CHANDWAR K
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    PubMed    


  50. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    PubMed     Abstract available


  51. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.
    PubMed    


  52. FRALICK M, Sarma S
    Thyrotoxic Periodic Paralysis.
    N Engl J Med. 2021;384:e71.
    PubMed    


  53. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    PubMed    


    April 2021
  54. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
    Case 13-2021: A Newborn Girl with a Neck Mass.
    N Engl J Med. 2021;384:1647-1655.
    PubMed    


  55. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    PubMed     Abstract available


  56. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    PubMed     Abstract available


  57. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Sutimlimab in Cold Agglutinin Disease.
    N Engl J Med. 2021;384:1323-1334.
    PubMed     Abstract available


  58. ZONOZI R, Niles JL
    Sunken Nose.
    N Engl J Med. 2021;384:e52.
    PubMed    


    March 2021
  59. BUTLER PC
    Supplying Insulin while Evading Immunity.
    N Engl J Med. 2021;384:967-969.
    PubMed    


    February 2021
  60. WARRINGTON KJ
    Avacopan - Time to Replace Glucocorticoids?
    N Engl J Med. 2021;384:664-665.
    PubMed    


  61. JAYNE DRW, Merkel PA, Schall TJ, Bekker P, et al
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:599-609.
    PubMed     Abstract available


  62. GOVERMAN JM
    Regulatory T Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:578-580.
    PubMed    


  63. WU C, Dai R
    Central Retinal Artery and Vein Occlusion.
    N Engl J Med. 2021;384:e9.
    PubMed    


    January 2021
  64. ZAMVIL SS, Hauser SL
    Antigen Presentation by B Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:378-381.
    PubMed    


  65. FURIE R, Rovin BH, Roth DA
    Belimumab in Lupus Nephritis. Reply.
    N Engl J Med. 2021;384:188.
    PubMed    


  66. SCHONERMARCK U, Kemmner S, Fischereder M
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187-188.
    PubMed    


  67. ROJAS-RIVERA J, Ortiz A, Carriazo S
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187.
    PubMed    


  68. ANDERSON MS, Chaimowitz NS, Forbes LR
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition. Reply.
    N Engl J Med. 2021;384:93-94.
    PubMed    


  69. JOHNSON MB, Hattersley AT, Patel KA
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition.
    N Engl J Med. 2021;384:93.
    PubMed    


    December 2020
  70. LEVY-LAHAD E, King MC
    Hiding in Plain Sight - Somatic Mutation in Human Disease.
    N Engl J Med. 2020;383:2680-2682.
    PubMed    


  71. BECK DB, Ferrada MA, Sikora KA, Ombrello AK, et al
    Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2020;383:2628-2638.
    PubMed     Abstract available


  72. BRETON MD, Beck RW, Wadwa RP
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2020;383:2484.
    PubMed    


  73. FERNANDES N
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:2484.
    PubMed    


  74. FAJGENBAUM DC, June CH
    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.
    PubMed    


    November 2020
  75. ADANG L, Goldbach-Mansky R, Vanderver A
    JAK Inhibition in the Aicardi-Goutieres Syndrome. Reply.
    N Engl J Med. 2020;383:2191-2193.
    PubMed    


  76. NEVEN B, Al Adba B, Hully M, Desguerre I, et al
    JAK Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:2190-2191.
    PubMed    


  77. ACCILI D
    Whither Type 1 Diabetes?
    N Engl J Med. 2020;383:2078-2079.
    PubMed    


  78. QUATTRIN T, Haller MJ, Steck AK, Felner EI, et al
    Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    N Engl J Med. 2020;383:2007-2017.
    PubMed     Abstract available


  79. CAPLAN DN, Rapalino O, Karaa A, Rosovsky RP, et al
    Case 35-2020: A 59-Year-Old Woman with Type 1 Diabetes Mellitus and Obtundation.
    N Engl J Med. 2020;383:1974-1983.
    PubMed    


  80. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
    PubMed    


    October 2020
  81. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    


  82. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    PubMed    


  83. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    PubMed    


  84. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    PubMed    


  85. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    PubMed    


  86. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    PubMed    


  87. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    PubMed    


  88. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    PubMed    


  89. GO JR, Abu Saleh OM
    Vancomycin-Induced Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;383:1577.
    PubMed    


  90. MIZUSHIMA N, Levine B
    Autophagy in Human Diseases.
    N Engl J Med. 2020;383:1564-1576.
    PubMed    


  91. OH JY
    Autoimmune Keratitis after Atezolizumab Treatment.
    N Engl J Med. 2020;383:1468.
    PubMed    


  92. CHAIMOWITZ NS, Ebenezer SJ, Hanson IC, Anderson M, et al
    STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.
    N Engl J Med. 2020;383:1494-1496.
    PubMed    


    September 2020
  93. WANG G, Li H, Yang X, Guo T, et al
    Guillain-Barre Syndrome Associated with JEV Infection.
    N Engl J Med. 2020;383:1188-1190.
    PubMed    


  94. WARD M, Tektonidou MG
    Belimumab as Add-on Therapy in Lupus Nephritis.
    N Engl J Med. 2020;383:1184-1185.
    PubMed    


  95. OSTENDORF L, Burns M, Durek P, Heinz GA, et al
    Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2020;383:1149-1155.
    PubMed     Abstract available


  96. FURIE R, Rovin BH, Houssiau F, Malvar A, et al
    Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
    N Engl J Med. 2020;383:1117-1128.
    PubMed     Abstract available


  97. BLUESTONE JA, Anderson M
    Tolerance in the Age of Immunotherapy.
    N Engl J Med. 2020;383:1156-1166.
    PubMed    


  98. TRAPNELL BC, Inoue Y, Bonella F, Morgan C, et al
    Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2020 Sep 7. doi: 10.1056/NEJMoa1913590.
    PubMed     Abstract available


  99. VANDERVER A, Adang L, Gavazzi F, McDonald K, et al
    Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:986-989.
    PubMed    


    August 2020
  100. BRETON MD, Kanapka LG, Beck RW, Ekhlaspour L, et al
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:836-845.
    PubMed     Abstract available


  101. MUELLER AA, Vaidya A, Tarter LL, Klein JP, et al
    Caught in a Flare.
    N Engl J Med. 2020;383:e48.
    PubMed    


  102. HAUSER SL, Bar-Or A, Cohen JA, Comi G, et al
    Ofatumumab versus Teriflunomide in Multiple Sclerosis.
    N Engl J Med. 2020;383:546-557.
    PubMed     Abstract available


    July 2020
  103. WU K
    Uncertain Trust.
    N Engl J Med. 2020;383:204-205.
    PubMed    


  104. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    PubMed    


  105. GAY E
    Blame.
    N Engl J Med. 2020;383:9.
    PubMed    


    June 2020
  106. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    PubMed    


  107. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    PubMed     Abstract available


  108. DORIA A, Galecki AT, Spino C, Pop-Busui R, et al
    Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    N Engl J Med. 2020;382:2493-2503.
    PubMed     Abstract available


  109. VICO-ALONSO C, Palencia-Perez S
    Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;382:2248.
    PubMed    


    May 2020
  110. WALSH M, Merkel PA, Jayne DRW
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2020;382:2169.
    PubMed    


  111. ESPOSITO P, Cipriani L, Viazzi F
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168-2169.
    PubMed    


  112. SEXTON DJ
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168.
    PubMed    


  113. DOUGLAS RS, Kahaly GJ
    Teprotumumab for Active Thyroid Eye Disease. Reply.
    N Engl J Med. 2020;382:1959-1960.
    PubMed    


  114. ROOS JCP, Hyry HI, Murthy R
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1959.
    PubMed    


  115. KIM S, Patzek S
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1958-1959.
    PubMed    


  116. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    PubMed    


    April 2020
  117. SOBRIN L, Stone JH, Huang AJ, Niles JL, et al
    Case 14-2020: A 37-Year-Old Man with Joint Pain and Eye Redness.
    N Engl J Med. 2020;382:1750-1758.
    PubMed    


  118. MORAND EF, Furie RA
    Anifrolumab in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2020;382:1666.
    PubMed    


  119. PUTMAN M
    Anifrolumab in Systemic Lupus Erythematosus.
    N Engl J Med. 2020;382:1665-1666.
    PubMed    


  120. LUNDQUIST AL, Kalim S, Mojtahed A, Tomaszewski KJ, et al
    Case 13-2020: A 29-Year-Old Man with High Blood Pressure, Renal Insufficiency, and Hematuria.
    N Engl J Med. 2020;382:1639-1647.
    PubMed    


  121. TOSCANO G, Palmerini F, Ravaglia S, Ruiz L, et al
    Guillain-Barre Syndrome Associated with SARS-CoV-2.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009191.
    PubMed    


  122. ZULFIQAR AA, Lorenzo-Villalba N, Hassler P, Andres E, et al
    Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2010472.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: